AGYSAgilysys, Inc.
Is the business good?
A genuinely good business: 8 of 9 health tests passed, earnings fully cash-backed (2.2×), and margins widening.
High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.
Operating profit is fully backed by cash. Conversion is worsening vs a year ago.
Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.
A balanced mix of margins, efficiency, and leverage. ROE 11% = margin × turnover × leverage.
Unless marked, from derived.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is AGYS?
Agilysys, Inc. keeps 15% of every revenue dollar as operating profit, against 6.9% for the median Software - Application name.
Operating margin · Software - Application median 6.9% · 12 months to Q1 2027
- Cash conversion
- 2.16×
Cash conversion · 3.84× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- +0.46%
Share count, year on year · flat: no meaningful dilution
- R&D as % of revenue
- 23%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2021 | −15% |
| FY2022 | 3.9% |
| FY2023 | 6.5% |
| FY2024 | 6.6% |
| FY2025 | 8.2% |
| FY2026 | 13% |
Details›
- Gross margin12 months to Q1 2027
- 63%
- Operating margin12 months to Q1 2027
- 15%
- Net margin12 months to Q1 2027
- 13%
- Free cash flow margin
- 24%
- R&D as % of revenue
- 23%
- Revenue, trailing twelve months
- $330M
- Free cash flow, trailing twelve months
- $80M
- Net income, trailing twelve months
- $43M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Software, Application
Ranks #38 of 92 by RyuScore